MedPath

Establishment of new index for prediction of the implantation success rate, combining the endometrial thickness, the size of the uterus and their ratio

Completed
Conditions
Sterility treatment
Pregnancy and Childbirth
Registration Number
ISRCTN19411490
Lead Sponsor
Vienna In Vitro Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
100
Inclusion Criteria

1. Women
2. Undergoing fertility treatment by stimulated IVF/ICSI, using the Antagonist Protocols
3. Transfer done on day 5 after the ovum pick up
4. Aged 20-45 years

Exclusion Criteria

1. Large or multiple fibroids
2. Uterine anomalies
3. Extremely small uterus APDUC bellow 25mm
4. BMI outside the range 19 - 29

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Endometrium thickness is measured using transvaginal ultrasound before the start of an IVF/ICSI cycle, and then on day 2-3, 5-8 and 9-11 of the IVF/ICSI cycle.<br>2. Uterine size is measured using transvaginal ultrasound before the start of an IVF/ICSI cycle, and then on day 2-3, 5-8 and 9-11 of the IVF/ICSI cycle
Secondary Outcome Measures
NameTimeMethod
IVF/ICSI success rate is measured using ßhCG on 10-13 day after the embryo transfer (to prove biochemical pregnancy) and transvaginal ultrasound on the day 20-25 after the embryo transfer (to prove clinical pregnancy).
© Copyright 2025. All Rights Reserved by MedPath